Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS
Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS
Indian Express
0 shares
1 views
You might like
Related news coverage
Bharat Biotech's COVID-19 vaccine 'Covaxin' commences phase-3 trial at AIIMS
The Phase-III human trials of indigenous Covid-19 vaccine Covaxin began at All India Institute of Medical Science (AIIMS) in New..
Mid-Day
Third phase trials of COVID-19 vaccine Covaxin begin
Vaccine maker Bharat Biotech on Monday announced that it has commenced Phase-3 trials of Covaxin, India's first indigenous vaccine..
Mid-Day